Skip to content

ABBV

AbbVie Inc.

Cash flow statement

Cash flow statement
Line, in USDLast 12 months202520242023202220212020201920182017201620152014201320122011
Operating cash flow20.1B19.0B18.8B22.8B24.9B22.8B17.6B13.3B13.4B10.0B7.0B7.5B3.5B6.3B6.3B6.2B
1.22B1.21B0.97B0.78B0.70B0.79B0.80B0.55B0.64B0.53B0.48B0.53B0.61B0.49B0.33B0.36B
Free cash flow18.9B17.8B17.8B22.1B24.2B22.0B16.8B12.8B12.8B9.4B6.6B7.0B2.9B5.8B6.0B5.9B
Depreciation and amortization7.71B8.14B8.39B8.70B8.47B8.52B6.47B2.02B1.77B1.50B1.19B0.84B0.79B0.90B1.15B1.27B
Stock-based compensation927M955M911M747M671M692M753M430M421M365M353M282M241M212M187M163M
Buybacks1.5B980M1.7B2.0B1.5B934M978M629M12.0B1.4B6.0B7.6B665M320M——
Dividends paid12.1B11.7B11.0B10.5B10.0B9.3B7.7B6.4B5.6B4.1B3.7B3.3B2.7B2.6B——
Dividends per share6.926.656.295.995.715.314.844.393.952.632.352.101.752.00——
Free cash flow margin28.6%29.1%31.7%40.6%41.8%39.1%36.7%38.4%39.0%33.4%25.6%30.6%14.7%30.7%32.7%33.8%